原薬市場レポート 2023-2033

Active Pharmaceutical Ingredients (APIs) Market Report 2023-2033

レポート詳細原薬市場レポート 2023-2033 :本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にある力学をより深く理解する上で貴重なものとなろう。異業種への進出や、新たな... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2023年8月8日	GBP4,500 部署ライセンスライセンス・価格情報注文方法はこちら	267	165	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

目次
図表リスト

サマリー

レポート詳細

原薬市場レポート 2023-2033:本レポートは、新たな収益の柱を目指す大手企業にとって、業界とその根底にある力学をより深く理解する上で貴重なものとなろう。異業種への進出や、新たな地域での既存事業の拡大を希望する企業にとっても有用であろう。

ジェネリック医薬品の需要増加で変貌する医薬品原薬市場
ジェネリック医薬品は、特に先発医薬品が高価である発展途上国において、医療アクセスを改善する上で重要な役割を果たしている。多くの政府は、医療費を削減し、国民の医薬品へのアクセスを向上させるため、ジェネリック医薬品の使用を積極的に推進している。世界的な高齢化により、慢性疾患の治療薬に対する需要が高まっており、ジェネリック医薬品が処方されるケースも多い。新興国における中間所得層の増加は医療費の増加を促し、その結果、手ごろな価格の医薬品に対する需要が高まっている。政府や規制機関はジェネリック医薬品の使用を積極的に奨励し、承認プロセスを容易にすることで、需要をさらに刺激しています。

高い製造コストが成長の可能性を制限する
原薬に関連する高い製造コストは、API市場の成長を妨げる可能性がある。使用される原料はAPI特有のものであるため、API開発プロセスで使用される原料成分の品質は極めて重要である。APIプロジェクトごとに新しい化学物質を設計するのは面倒で複雑である。さらに、原薬製造工程は幅広い化学的・生物学的プロセスを含む複雑なメカニズムである。原薬メーカーは多くの場合、特定の薬に含まれる原薬のサイズと強度を決定するために、決められた規制を採用している。これらの要因が原薬製造プロセスのコストを押し上げ、当面の間、原薬市場の成長を妨げる可能性がある。

市場調査レポートを購入する前にすべき質問とは？
- 原薬市場はどのように進化しているのか？
- 原薬市場の牽引役と抑制要因は何か？
- 原薬サブマーケットの各セグメントは予測期間中にどのように成長し、2033年にどれくらいの収益を占めるのか？
- 2023年から2033年にかけて、各原薬サブマーケットの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて、市場全体を牽引する主な要因は何か？
- 主要な原薬市場はマクロ経済の動きに概ね追随するのか、それとも個々の国市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどう変化し、2033年に市場をリードするのはどの地域か？
- 主要プレイヤーは誰で、予測期間中の見通しは？
- 主要企業の原薬プロジェクトは？
- 2023年から2033年の間に、業界はどのように発展するのか？現在および今後10年間の原薬プロジェクトにはどのような意味があるのか？
- 原薬市場をさらに拡大するために、製品化の必要性は高まっていますか？
- 原薬市場はどこに向かっているのか、また、どのようにすれば市場の最前線に立てるのか？
- 新製品やサービスラインへの最適な投資方法とは？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

現在、そして今後10年間、原薬市場にどのような影響を与えるかを見極める必要がある：
- 267ページにわたる本レポートでは、98の表と167の図表を掲載しています。
- 本レポートでは、業界における主要な有利分野を取り上げているため、今すぐターゲットを絞ることができます。
- 世界、地域、国の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。

本レポートは、原薬市場が今後10年間でどのように発展していくのか、またCOVID-19の景気後退と好転の変動に合わせてどのように発展していくのかをお伝えします。この市場は、過去10年間のどの時点よりも今が重要です。

2033年までの予測やその他の分析から、商業的な展望が明らかになる
- 2033年までの収益予測に加え、直近の業績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望と展開に関する独自の分析をご覧いただけます。
- 質的分析（市場ダイナミクス、促進要因、機会、阻害要因、課題を含む）、コスト構造、原薬価格上昇の影響、最新動向をご覧いただけます。

本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。

レポート対象セグメント

治療応用
- 腫瘍学
- 抗糖尿病薬
- 呼吸器内科
- 免疫抑制剤
- 神経学
- 循環器内科
- 眼科
- 整形外科
- その他

合成タイプ
- 合成
- バイオテクノロジー

メーカー
- マーチャントAPI
- キャプティブAPI

医薬品タイプ
- ブランド
- ジェネリック

世界市場全体とセグメント別の収益予測に加え、4つの地域と20の主要国市場の収益予測も掲載しています：

北米
- アメリカ
- カナダ

欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- その他の欧州

アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ

MEA
- GCC
- 南アフリカ
- その他のMEA

報告書に掲載された主要企業
・ Aarti Drugs Ltd.
・ Aurobindo Pharma
・ Biocon
・ Cipla Inc.
・ Divi’s Laboratories Limited
・ Dr. Reddy’s Laboratories Ltd.
・ EUROAPI
・ HIKAL Ltd.
・ Merck ＆ Co., Inc.
・ Teva Pharmaceutical Industries Ltd.

2023年から2033年までの原薬市場全体の世界売上高は、金額ベースで2023年に2,350億米ドルを突破する。2033年まで力強い収益成長を予測。当社の調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を発見し、あなたが一歩先を行くのを支援します。

原薬市場、2023-2033年レポートはどのようにお役に立ちますか？
要約すると、260ページを超えるこのレポートは、以下の知識を提供する：

- 原薬市場の2033年までの収益予測（治療用途、合成タイプ、メーカー、薬剤タイプ別、それぞれ世界・地域レベルで予測） - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけることができます。

- 5つの地域と20の主要国市場の2033年までの収益予測 - 原薬市場、2023年から2033年までの北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEAの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要国の市場も予測しています。

- 2023年から2033年までの原薬市場に関わる主要企業10社の企業プロファイルを含む、既存企業および市場参入を目指す企業の展望。
独自の予測による定量的・定性的分析をご覧いただけます。貴重なビジネスインテリジェンスで常に情報を得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。弊社のレポートが貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、2023年から2033年までの原薬市場の商業分析を必要とするすべての人、市場をリードする企業のためのものです。データ、トレンド、予測をご覧いただけます。

ページTOPに戻る

1 レポート概要
1.1 研究の目的
1.2 原薬市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて

2 エグゼクティブ・サマリー

3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.1 慢性疾患の増加
3.2.1.2 医薬品研究開発活動の活発化
3.2.1.3 ジェネリック医薬品の需要増加
3.2.1.4 バイオ医薬品の利用増加
3.2.2 市場抑制要因
3.2.2.1 不利な薬価統制政策
3.2.2.2 高い製造コスト
3.2.3 市場機会
3.2.3.1 特殊原薬の需要増加
3.2.3.2 個別化医薬品への嗜好の高まり
3.3 COVID-19の影響分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの交渉力
3.4.2 買い手の交渉力
3.4.3 競争相手のライバル関係
3.4.4 代替品による脅威
3.4.5 新規参入企業の脅威
3.5 PEST分析

4 原薬市場分析：治療用途別
4.1 主な調査結果
4.2 治療用途セグメント市場魅力度指数
4.3 治療用途別原薬市場規模の推定と予測
4.4 がん領域
4.4.1 2023〜2033年の地域別市場規模（US$ Billion）
4.4.2 地域別市場シェア、2023年・2033年(%)
4.5 抗糖尿病薬
4.5.1 2023〜2033年の地域別市場規模（US$ Billion）
4.5.2 地域別市場シェア、2023年・2033年(%)
4.6 呼吸器領域
4.6.1 2023〜2033年の地域別市場規模（US$ Billion）
4.6.2 地域別市場シェア、2023年・2033年(%)
4.7 免疫抑制剤
4.7.1 2023〜2033年の地域別市場規模（US$ Billion）
4.7.2 地域別市場シェア、2023年・2033年(%)
4.8 神経領域
4.8.1 2023〜2033年の地域別市場規模（US$ Billion）
4.8.2 地域別市場シェア、2023年・2033年(%)
4.9 循環器内科
4.9.1 2023〜2033年の地域別市場規模（US$ Billion）
4.9.2 地域別市場シェア、2023年・2033年(%)
4.10 眼科
4.10.1 2023〜2033年の地域別市場規模（US$ Billion）
4.10.2 地域別市場シェア、2023年・2033年(%)
4.11 整形外科
4.11.1 2023〜2033年の地域別市場規模（US$ Billion）
4.11.2 地域別市場シェア、2023年・2033年(%)
4.12 その他
4.12.1 2023〜2033年の地域別市場規模（US$ Billion）
4.12.2 地域別市場シェア、2023年・2033年(%)

5 原薬市場分析：合成タイプ別
5.1 主要な調査結果
5.2 合成タイプ別セグメント市場魅力度指数
5.3 合成タイプ別原薬市場規模の推定と予測
5.4 合成
5.4.1 2023〜2033年の地域別市場規模（US$ Billion）
5.4.2 地域別市場シェア、2023年・2033年(%)
5.5 バイオテクノロジー
5.5.1 2023〜2033年の地域別市場規模（US$ Billion）
5.5.2 地域別市場シェア、2023年・2033年(%)

6 原薬市場分析：メーカー別
6.1 主要な調査結果
6.2 メーカーセグメント市場魅力度指数
6.3 原薬メーカー別市場規模推定と予測
6.4 マーチャント原薬
6.4.1 2023〜2033年の地域別市場規模（US$ Billion）
6.4.2 地域別市場シェア、2023年・2033年(%)
6.5 キャプティブAPI
6.5.1 2023～2033年の地域別市場規模（US$ Billion）
6.5.2 地域別市場シェア、2023年及び2033年(%)

7 原薬市場分析：薬剤タイプ別
7.1 主要な調査結果
7.2 薬剤タイプ別セグメント市場魅力度指数
7.3 薬剤タイプ別原薬市場規模の推定と予測
7.4 ブランド
7.4.1 2023〜2033年の地域別市場規模（US$ Billion）
7.4.2 地域別市場シェア、2023年・2033年(%)
7.5 ジェネリック
7.5.1 2023〜2033年の地域別市場規模（US$ Billion）
7.5.2 地域別市場シェア、2023年・2033年(%)

8 原薬市場分析：地域別
8.1 主要な調査結果
8.2 地域別市場規模の推定と予測

9 北米の原薬市場分析
9.1 主要な調査結果
9.2 北米の原薬市場魅力度指数
9.3 北米の原薬市場の国別市場規模、2023年、2028年、2033年（US$ Billion）
9.4 北米の原薬市場規模推定と予測：国別
9.5 北米の原薬市場規模推定と予測：治療用途別
9.6 北米の原薬市場規模推定と予測：合成タイプ別
9.7 北米の原薬市場規模推定と予測：メーカー別
9.8 北米の原薬市場規模推定と予測：薬剤タイプ別
9.9 アメリカの原薬市場分析
9.10 カナダの原薬市場分析

10 欧州原薬市場分析
10.1 主要な調査結果
10.2 欧州の原薬市場魅力度指数
10.3 欧州の原薬国別市場、2023年、2028年、2033年（US$ Billion）
10.4 欧州の原薬市場規模推定と予測：国別
10.5 欧州の原薬市場規模推定と予測：治療用途別
10.6 欧州の原薬市場規模推定と予測：合成タイプ別
10.7 欧州の原薬市場規模推定と予測：メーカー別
10.8 欧州の原薬市場規模推定と予測：薬剤タイプ別
10.9 ドイツの原薬市場分析
10.10 フランスの原薬市場分析
10.11 イギリスの原薬市場分析
10.12 イタリアの原薬市場分析
10.13 スペインの原薬市場分析
10.14 ロシアの原薬市場分析
10.15 その他の欧州の原薬市場分析

11 アジア太平洋地域の原薬市場分析
11.1 主要な調査結果
11.2 アジア太平洋地域の原薬市場魅力度指数
11.3 アジア太平洋地域の原薬国別市場、2023年、2028年、2033年（US$ Billion）
11.4 アジア太平洋地域の原薬市場規模推定と予測：国別
11.5 アジア太平洋地域の原薬市場規模推定と予測：治療用途別
11.6 アジア太平洋地域の原薬市場規模推定と予測：合成タイプ別
11.7 アジア太平洋地域の原薬市場規模推定と予測：メーカー別
11.8 アジア太平洋地域の原薬市場規模推定と予測：薬剤タイプ別
11.9 日本の原薬市場分析
11.10 中国の原薬市場分析
11.11 インドの原薬市場分析
11.12 オーストラリアの原薬市場分析
11.13 韓国の原薬市場分析
11.14 その他のアジア太平洋地域の原薬市場分析

12 ラテンアメリカの原薬市場分析
12.1 主要な調査結果
12.2 ラテンアメリカの原薬市場魅力度指数
12.3 ラテンアメリカの原薬国別市場、2023年、2028年、2033年（US$ Billion）
12.4 ラテンアメリカの原薬市場規模推定と予測：国別
12.5 ラテンアメリカの原薬市場規模推定と予測：治療用途別
12.6 ラテンアメリカの原薬市場規模推定と予測：合成タイプ別
12.7 ラテンアメリカの原薬市場規模推定と予測：製造業者別
12.8 ラテンアメリカの原薬市場規模推定と予測：医薬品タイプ別
12.9 ブラジルの原薬市場分析
12.10 メキシコの原薬市場分析
12.11 その他のラテンアメリカ原薬市場分析

13 MEAの原薬市場分析
13.1 主要な調査結果
13.2 MEA原薬の市場魅力度指数
13.3 MEA原薬の国別市場規模、2023年、2028年、2033年（US$ Billion）
13.4 MEA原薬の市場規模推定と予測：国別
13.5 MEA原薬の市場規模推定と予測：治療用途別
13.6 MEA原薬の市場規模推定と予測：合成タイプ別
13.7 MEA原薬の市場規模推定と予測：メーカー別
13.8 MEA原薬の市場規模推定と予測：医薬品タイプ別
13.9 GCCの原薬市場分析
13.10 南アフリカの原薬市場分析
13.11 その他のMEA原薬市場分析

14 主要企業のプロファイル
14.1 競争環境、2022年
14.2 戦略的展望
14.3 Aarti Drugs Ltd.
14.3.1 会社概要
14.3.2 会社概要
14.3.3 財務分析
14.3.3.1 純収入、2017-2022年
14.3.3.2 R＆D、2017-2022年
14.3.3.3 地域市場シェア、2022年
14.3.4 製品ベンチマーク
14.4 Aurobindo Pharma
14.4.1 会社概要
14.4.2 会社概要
14.4.3 財務分析
14.4.3.1 純収入、2017-2022年
14.4.3.2 R＆D、2017-2022年
14.4.3.3 地域市場シェア、2022年
14.4.4 製品ベンチマーク
14.5 Biocon
14.5.1 会社概要
14.5.2 会社概要
14.5.3 財務分析
14.5.3.1 純収入、2017-2022年
14.5.3.2 R＆D、2017-2022年
14.5.3.3 地域市場シェア、2022年
14.5.4 製品ベンチマーク
14.5.5 戦略的展望
14.6 Cipla Inc.
14.6.1 会社概要
14.6.2 会社概要
14.6.3 財務分析
14.6.3.1 純収入、2017-2022年
14.6.3.2 R＆D、2017-2022年
14.6.3.3 地域市場シェア、2022年
14.6.4 製品ベンチマーク
14.6.5 戦略的展望
14.7 Divi's Laboratories Limited
14.7.1 会社概要
14.7.2 会社概要
14.7.3 財務分析
14.7.3.1 純収入、2017-2022年
14.7.3.2 売上高、2017-2022年
14.7.3.3 地域市場シェア、2022年
14.7.4 製品ベンチマーク
14.8 Dr. Reddy’s Laboratories Ltd.
14.8.1 会社概要
14.8.2 会社概要
14.8.3 財務分析
14.8.3.1 純収入、2017-2022年
14.8.3.2 R＆D、2017-2022年
14.8.3.3 地域市場シェア、2022年
14.8.4 製品ベンチマーク
14.8.5 戦略的展望
14.9 EUROAPI
14.9.1 会社概要
14.9.2 会社概要
14.9.3 財務分析
14.9.3.1 純収入、2017-2022年
14.9.3.2 売上高、2017-2022年
14.9.4 製品ベンチマーク
14.9.5 戦略的展望
14.10 HIKAL Ltd.
14.10.1 会社概要
14.10.2 会社概要
14.10.3 財務分析
14.10.3.1 純収入、2017-2022年
14.10.3.2 売上高、2017-2022年
14.10.4 製品ベンチマーク
14.10.5 戦略的展望
14.11 Merck & Co., Inc.
14.11.1 会社概要
14.11.2 会社概要
14.11.3 財務分析
14.11.3.1 純収入、2017-2022年
14.11.3.2 売上高、2017-2022年
14.11.3.3 地域市場シェア、2022年
14.11.4 製品ベンチマーク
14.11.5 戦略的展望
14.12 Teva Pharmaceutical Industries Ltd.
14.12.1 会社概要
14.12.2 会社概要
14.12.3 財務分析
14.12.3.1 純収入、2017-2022年
14.12.3.2 R＆D、2017年-2022年
14.12.3.3 地域市場シェア、2022年
14.12.4 製品ベンチマーク

15 結論と提言
15.1 Visiongainからの結びの言葉
15.2 市場プレイヤーへの提言

ページTOPに戻る

図表リスト

表の一覧
Table 1 Active Pharmaceutical Ingredients Market Snapshot, 2023 & 2033 (US$ Billion, CAGR %)
Table 2 Active Pharmaceutical Ingredients Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Active Pharmaceutical Ingredients Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Active Pharmaceutical Ingredients Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Active Pharmaceutical Ingredients Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 7 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 8 Anti-diabetics Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 9 Pulmonology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 10 Immuno-suppressants Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 11 Neurology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 12 Cardiology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 13 Ophthalmology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 14 Orthopaedic Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 15 Others Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 16 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 17 Synthetic Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 18 Biotech Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 19 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 20 Merchant API Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 21 Captive API Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 22 Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 23 Branded Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 24 Generic Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 25 Active Pharmaceutical Ingredients Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 26 North America Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 27 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 28 North America Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 29 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 30 North America Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 31 U.S. Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 32 Canada Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 33 Europe Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 34 Europe Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 35 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 36 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 37 Europe Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 38 Germany Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 39 France Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 40 UK Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 41 Italy Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 42 Spain Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 43 Russia Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 44 Rest of Europe Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 45 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 46 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 47 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 48 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 49 Asia Pacific Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 50 Japan Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 51 China Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 52 India Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 53 Australia Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 54 South Korea Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 55 Rest of Asia Pacific Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 56 Latin America Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 57 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 58 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 59 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 60 Latin America Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 61 Brazil Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 62 Mexico Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 63 Rest of Latin America Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 64 MEA Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 65 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 66 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 67 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 68 MEA Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 69 GCC Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 70 South Africa Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 71 Rest of MEA Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 72 Strategic Outlook
Table 73 Aarti Drugs Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Aarti Drugs Ltd.: Product Benchmarking
Table 75 Aurobindo Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Aurobindo Pharma: Product Benchmarking
Table 77 Biocon: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 Biocon: Product Benchmarking
Table 79 Biocon: Strategic Outlook
Table 80 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Cipla Inc.: Product Benchmarking
Table 82 Cipla Inc.: Strategic Outlook
Table 83 Divi's Laboratories Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Divi's Laboratories Limited: Product Benchmarking
Table 85 Dr. Reddy’s Laboratories Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Dr. Reddy’s Laboratories Ltd.: Product Benchmarking
Table 87 Dr. Reddy’s Laboratories Ltd.: Strategic Outlook
Table 88 EUROAPI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 EUROAPI: Product Benchmarking
Table 90 EUROAPI: Strategic Outlook
Table 91 HIKAL Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 HIKAL Ltd.: Product Benchmarking
Table 93 HIKAL Ltd.: Strategic Outlook
Table 94 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Merck & Co., Inc.: Product Benchmarking
Table 96 Merck & Co., Inc.: Strategic Outlook
Table 97 Teva Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Teva Pharmaceutical Industries Ltd.: Product Benchmarking

図の一覧
Figure 1 Active Pharmaceutical Ingredients Market Segmentation
Figure 2 Active Pharmaceutical Ingredients Market by Therapeutic Application: Market Attractiveness Index
Figure 3 Active Pharmaceutical Ingredients Market by Synthesis Type: Market Attractiveness Index
Figure 4 Active Pharmaceutical Ingredients Market by Manufacturer: Market Attractiveness Index
Figure 5 Active Pharmaceutical Ingredients Market by Drug Type: Market Attractiveness Index
Figure 6 Active Pharmaceutical Ingredients Market Attractiveness Index by Region
Figure 7 Active Pharmaceutical Ingredients Market: Market Dynamics
Figure 8 Active Pharmaceutical Ingredients Market by Region, 2023-2033 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 9 Active Pharmaceutical Ingredients Market by Region, 2023-2033 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 10 Active Pharmaceutical Ingredients Market by Region, 2023-2033 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 11 Active Pharmaceutical Ingredients Market by Region, 2023-2033 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 12 Active Pharmaceutical Ingredients Market: Porter’s Five Forces Analysis
Figure 13 Active Pharmaceutical Ingredients Market: PEST Analysis
Figure 14 Active Pharmaceutical Ingredients Market by Therapeutic Application: Market Attractiveness Index
Figure 15 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 16 Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023, 2028, 2033 (%)
Figure 17 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 18 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Anti-diabetics Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 20 Anti-diabetics Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Pulmonology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 22 Pulmonology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Immuno-suppressants Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 24 Immuno-suppressants Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Neurology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 26 Neurology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Cardiology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 28 Cardiology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Ophthalmology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 30 Ophthalmology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Orthopaedic Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 32 Orthopaedic Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 Others Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 34 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 35 Active Pharmaceutical Ingredients Market by Synthesis Type: Market Attractiveness Index
Figure 36 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 37 Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023, 2028, 2033 (%)
Figure 38 Synthetic Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 39 Synthetic Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 Biotech Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 41 Biotech Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 42 Active Pharmaceutical Ingredients Market by Manufacturer: Market Attractiveness Index
Figure 43 Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 44 Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023, 2028, 2033 (%)
Figure 45 Merchant API Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 46 Merchant API Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Captive API Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 48 Captive API Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Active Pharmaceutical Ingredients Market by Drug Type: Market Attractiveness Index
Figure 50 Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 51 Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023, 2028, 2033 (%)
Figure 52 Branded Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 53 Branded Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Generic Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 55 Generic Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Active Pharmaceutical Ingredients Market Forecast by Region 2023 and 2033 (Revenue, CAGR %)
Figure 57 Active Pharmaceutical Ingredients Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 58 Active Pharmaceutical Ingredients Market by Region, 2023-2033 (US$ Billion, AGR %)
Figure 59 North America Active Pharmaceutical Ingredients Market Attractiveness Index
Figure 60 North America Active Pharmaceutical Ingredients Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 61 North America Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 62 North America Active Pharmaceutical Ingredients Market Share Forecast by Country, 2023 & 2033 (%)
Figure 63 North America Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 64 North America Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023 & 2033 (%)
Figure 65 North America Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 66 North America Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023 & 2033 (%)
Figure 67 North America Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 68 North America Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023 & 2033 (%)
Figure 69 North America Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 70 North America Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 71 U.S. Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 72 Canada Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 73 Europe Active Pharmaceutical Ingredients Market Attractiveness Index
Figure 74 Europe Active Pharmaceutical Ingredients Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 75 Europe Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 76 Europe Active Pharmaceutical Ingredients Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 Europe Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 78 Europe Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023 & 2033 (%)
Figure 79 Europe Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 80 Europe Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023 & 2033 (%)
Figure 81 Europe Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 82 Europe Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023 & 2033 (%)
Figure 83 Europe Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 84 Europe Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 85 Germany Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 86 France Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 87 UK Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 88 Italy Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 89 Spain Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 90 Russia Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 91 Rest of Europe Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 92 Asia Pacific Active Pharmaceutical Ingredients Market Attractiveness Index
Figure 93 Asia Pacific Active Pharmaceutical Ingredients Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 94 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 95 Asia Pacific Active Pharmaceutical Ingredients Market Share Forecast by Country, 2023 & 2033 (%)
Figure 96 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 97 Asia Pacific Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023 & 2033 (%)
Figure 98 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 99 Asia Pacific Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023 & 2033 (%)
Figure 100 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 101 Asia Pacific Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023 & 2033 (%)
Figure 102 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 103 Asia Pacific Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 104 Japan Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 105 China Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 106 India Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 107 Australia Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 108 South Korea Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 109 Rest of Asia Pacific Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 110 Latin America Active Pharmaceutical Ingredients Market Attractiveness Index
Figure 111 Latin America Active Pharmaceutical Ingredients Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 112 Latin America Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 113 Latin America Active Pharmaceutical Ingredients Market Share Forecast by Country, 2023 & 2033 (%)
Figure 114 Latin America Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 115 Latin America Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023 & 2033 (%)
Figure 116 Latin America Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 117 Latin America Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023 & 2033 (%)
Figure 118 Latin America Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 119 Latin America Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023 & 2033 (%)
Figure 120 Latin America Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 121 Latin America Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 122 Brazil Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 123 Mexico Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 124 Rest of Latin America Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 125 MEA Active Pharmaceutical Ingredients Market Attractiveness Index
Figure 126 MEA Active Pharmaceutical Ingredients Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 127 MEA Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 128 MEA Active Pharmaceutical Ingredients Market Share Forecast by Country, 2023 & 2033 (%)
Figure 129 MEA Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 130 MEA Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023 & 2033 (%)
Figure 131 MEA Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 132 MEA Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023 & 2033 (%)
Figure 133 MEA Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 134 MEA Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023 & 2033 (%)
Figure 135 MEA Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 136 MEA Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 137 GCC Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 138 South Africa Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 139 Rest of MEA Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 140 Aarti Drugs Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 141 Aarti Drugs Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 142 Aarti Drugs Ltd.: Regional Market Shares, 2022
Figure 143 Aurobindo Pharma: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 144 Aurobindo Pharma: R&D, 2017-2022 (US$ Million, AGR%)
Figure 145 Aurobindo Pharma: Regional Market Shares, 2022
Figure 146 Biocon: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 147 Biocon: R&D, 2017-2022 (US$ Million, AGR%)
Figure 148 Biocon: Regional Market Shares, 2022
Figure 149 Cipla Ltd: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 150 Cipla Ltd: R&D, 2017-2022 (US$ Million, AGR %)
Figure 151 Cipla Inc.: Regional Market Shares, 2022
Figure 152 Divi's Laboratories Limited: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 153 Divi's Laboratories Limited: R&D, 2017-2022 (US$ Million, AGR%)
Figure 154 Divi's Laboratories Limited: Regional Market Shares, 2022
Figure 155 Dr. Reddy’s Laboratories Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 156 Dr. Reddy’s Laboratories Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 157 Dr. Reddy’s Laboratories Ltd.: Regional Market Shares, 2022
Figure 158 EUROAPI: Net Revenue, 2019-2022 (US$ Million, AGR%)
Figure 159 EUROAPI: R&D, 2021-2022 (US$ Million, AGR%)
Figure 160 HIKAL Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 161 HIKAL Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 162 Merck & Co., Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 163 Merck & Co., Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 164 Merck & Co., Inc.: Regional Market Shares, 2022
Figure 165 Teva Pharmaceutical Industries Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 166 Teva Pharmaceutical Industries Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 167 Teva Pharmaceutical Industries Ltd.: Regional Market Shares, 2022

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Report Details

The Active Pharmaceutical Ingredients (APIs) Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Active Pharmaceutical Ingredients Market is being Transformed by Increasing Demand for Generics
Generics play a vital role in improving healthcare access, particularly in developing countries where brand-name drugs can be costly. Many governments actively promote the use of generic drugs to reduce healthcare expenditures and enhance access to medications for their citizens. The aging global population increases the demand for medications for chronic conditions, with generic drugs often being prescribed for such cases. Growing middle-class populations in emerging economies drive increased healthcare expenditures, resulting in a higher demand for affordable medications. Governments and regulatory bodies have actively encouraged the use of generics and facilitated easier approval processes, further stimulating demand.

High Manufacturing Cost will Limit the Growth Potential
The high manufacturing cost associated with active pharmaceutical ingredients may hamper API market growth. The raw materials used are API-specific, so the quality of the raw material components used in the API development process is critical. Designing a new chemistry for each API project is tedious and complicated. Furthermore, the drug substance manufacturing process is a complex mechanism involving a wide range of chemical and biological processes. The API manufacturers often employ set regulations to determine the size and strength of an API in a certain medication. These factors drive the cost of API manufacturing processes and may hinder API market growth for the foreseeable future.

What Questions Should You Ask before Buying a Market Research Report?
• How is the Active Pharmaceutical Ingredients Market evolving?
• What is driving and restraining the Active Pharmaceutical Ingredients Market?
• How will each Active Pharmaceutical Ingredients submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Active Pharmaceutical Ingredients submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Active Pharmaceutical Ingredients Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Active Pharmaceutical Ingredients projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Active Pharmaceutical Ingredients projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Active Pharmaceutical Ingredients Market?
• Where is the Active Pharmaceutical Ingredients Market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Active Pharmaceutical Ingredients Market today, and over the next 10 years:
• Our 267-page report provides 98 tables and 167 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Active Pharmaceutical Ingredients Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Active Pharmaceutical Ingredients prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Therapeutic Application
• Oncology
• Anti-diabetics
• Pulmonology
• Immuno-suppressants
• Neurology
• Cardiology
• Ophthalmology
• Orthopedic
• Others

Synthesis Type
• Synthetic
• Biotech

Manufacturer
• Merchant API
• Captive API

Drug Type
• Branded
• Generic

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

Leading companies profiled in the report
• Aarti Drugs Ltd.
• Aurobindo Pharma
• Biocon
• Cipla Inc.
• Divi’s Laboratories Limited
• Dr. Reddy’s Laboratories Ltd.
• EUROAPI
• HIKAL Ltd.
• Merck & Co., Inc.
• Teva Pharmaceutical Industries Ltd.

Overall world revenue for Active Pharmaceutical Ingredients Market, 2023 to 2033 in terms of value the market will surpass US$235 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Active Pharmaceutical Ingredients Market, 2023 to 2033 report help you?
In summary, our 260+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Active Pharmaceutical Ingredients Market with forecasts for therapeutic application, synthesis type, manufacturer, and drug type, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 20 key national markets – See forecasts for the Active Pharmaceutical Ingredients Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Active Pharmaceutical Ingredients Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Active Pharmaceutical Ingredients Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Active Pharmaceutical Ingredients Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Prevalence of Chronic Diseases
3.2.1.2 Rising Drug Research and Development Activities
3.2.1.3 Increasing Demand for Generics
3.2.1.4 Increasing Uptake of Biopharmaceuticals
3.2.2 Market Restraining Factors
3.2.2.1 Unfavourable Drug Price Control Policies
3.2.2.2 High Manufacturing Costs
3.2.3 Market Opportunities
3.2.3.1 Increasing Demand for Specialty APIs
3.2.3.2 Growing Preference for Personalized Medicines
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Active Pharmaceutical Ingredients Market Analysis by Therapeutic Application
4.1 Key Findings
4.2 Therapeutic Application Segment: Market Attractiveness Index
4.3 Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
4.4 Oncology
4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Anti-diabetics
4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Pulmonology
4.6.1 Market Size by Region, 2023-2033 (US$ Billion)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Immuno-suppressants
4.7.1 Market Size by Region, 2023-2033 (US$ Billion)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Neurology
4.8.1 Market Size by Region, 2023-2033 (US$ Billion)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Cardiology
4.9.1 Market Size by Region, 2023-2033 (US$ Billion)
4.9.2 Market Share by Region, 2023 & 2033 (%)
4.10 Ophthalmology
4.10.1 Market Size by Region, 2023-2033 (US$ Billion)
4.10.2 Market Share by Region, 2023 & 2033 (%)
4.11 Orthopaedic
4.11.1 Market Size by Region, 2023-2033 (US$ Billion)
4.11.2 Market Share by Region, 2023 & 2033 (%)
4.12 Others
4.12.1 Market Size by Region, 2023-2033 (US$ Billion)
4.12.2 Market Share by Region, 2023 & 2033 (%)

5 Active Pharmaceutical Ingredients Market Analysis by Synthesis Type
5.1 Key Findings
5.2 Synthesis Type Segment: Market Attractiveness Index
5.3 Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
5.4 Synthetic
5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Biotech
5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
5.5.2 Market Share by Region, 2023 & 2033 (%)

6 Active Pharmaceutical Ingredients Market Analysis by Manufacturer
6.1 Key Findings
6.2 Manufacturer Segment: Market Attractiveness Index
6.3 Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
6.4 Merchant API
6.4.1 Market Size by Region, 2023-2033 (US$ Billion)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Captive API
6.5.1 Market Size by Region, 2023-2033 (US$ Billion)
6.5.2 Market Share by Region, 2023 & 2033 (%)

7 Active Pharmaceutical Ingredients Market Analysis by Drug Type
7.1 Key Findings
7.2 Drug Type Segment: Market Attractiveness Index
7.3 Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
7.4 Branded
7.4.1 Market Size by Region, 2023-2033 (US$ Billion)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Generic
7.5.1 Market Size by Region, 2023-2033 (US$ Billion)
7.5.2 Market Share by Region, 2023 & 2033 (%)

8 Active Pharmaceutical Ingredients Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Active Pharmaceutical Ingredients Market Analysis
9.1 Key Findings
9.2 North America Active Pharmaceutical Ingredients Market Attractiveness Index
9.3 North America Active Pharmaceutical Ingredients Market by Country, 2023, 2028 & 2033 (US$ Billion)
9.4 North America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Country
9.5 North America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
9.6 North America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
9.7 North America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
9.8 North America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
9.9 U.S. Active Pharmaceutical Ingredients Market Analysis
9.10 Canada Active Pharmaceutical Ingredients Market Analysis

10 Europe Active Pharmaceutical Ingredients Market Analysis
10.1 Key Findings
10.2 Europe Active Pharmaceutical Ingredients Market Attractiveness Index
10.3 Europe Active Pharmaceutical Ingredients Market by Country, 2023, 2028 & 2033 (US$ Billion)
10.4 Europe Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Country
10.5 Europe Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
10.6 Europe Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
10.7 Europe Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
10.8 Europe Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
10.9 Germany Active Pharmaceutical Ingredients Market Analysis
10.10 France Active Pharmaceutical Ingredients Market Analysis
10.11 UK Active Pharmaceutical Ingredients Market Analysis
10.12 Italy Active Pharmaceutical Ingredients Market Analysis
10.13 Spain Active Pharmaceutical Ingredients Market Analysis
10.14 Russia Active Pharmaceutical Ingredients Market Analysis
10.15 Rest of Europe Active Pharmaceutical Ingredients Market Analysis

11 Asia Pacific Active Pharmaceutical Ingredients Market Analysis
11.1 Key Findings
11.2 Asia Pacific Active Pharmaceutical Ingredients Market Attractiveness Index
11.3 Asia Pacific Active Pharmaceutical Ingredients Market by Country, 2023, 2028 & 2033 (US$ Billion)
11.4 Asia Pacific Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Country
11.5 Asia Pacific Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
11.6 Asia Pacific Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
11.7 Asia Pacific Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
11.8 Asia Pacific Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
11.9 Japan Active Pharmaceutical Ingredients Market Analysis
11.10 China Active Pharmaceutical Ingredients Market Analysis
11.11 India Active Pharmaceutical Ingredients Market Analysis
11.12 Australia Active Pharmaceutical Ingredients Market Analysis
11.13 South Korea Active Pharmaceutical Ingredients Market Analysis
11.14 Rest of Asia Pacific Active Pharmaceutical Ingredients Market Analysis

12 Latin America Active Pharmaceutical Ingredients Market Analysis
12.1 Key Findings
12.2 Latin America Active Pharmaceutical Ingredients Market Attractiveness Index
12.3 Latin America Active Pharmaceutical Ingredients Market by Country, 2023, 2028 & 2033 (US$ Billion)
12.4 Latin America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Country
12.5 Latin America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
12.6 Latin America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
12.7 Latin America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
12.8 Latin America Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
12.9 Brazil Active Pharmaceutical Ingredients Market Analysis
12.10 Mexico Active Pharmaceutical Ingredients Market Analysis
12.11 Rest of Latin America Active Pharmaceutical Ingredients Market Analysis

13 MEA Active Pharmaceutical Ingredients Market Analysis
13.1 Key Findings
13.2 MEA Active Pharmaceutical Ingredients Market Attractiveness Index
13.3 MEA Active Pharmaceutical Ingredients Market by Country, 2023, 2028 & 2033 (US$ Billion)
13.4 MEA Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Country
13.5 MEA Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Therapeutic Application
13.6 MEA Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Synthesis Type
13.7 MEA Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Manufacturer
13.8 MEA Active Pharmaceutical Ingredients Market Size Estimation and Forecast by Drug Type
13.9 GCC Active Pharmaceutical Ingredients Market Analysis
13.10 South Africa Active Pharmaceutical Ingredients Market Analysis
13.11 Rest of MEA Active Pharmaceutical Ingredients Market Analysis

14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Strategic Outlook
14.3 Aarti Drugs Ltd.
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2022
14.3.3.2 R&D, 2017-2022
14.3.3.3 Regional Market Shares, 2022
14.3.4 Product Benchmarking
14.4 Aurobindo Pharma
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2017-2022
14.4.3.2 R&D, 2017-2022
14.4.3.3 Regional Market Shares, 2022
14.4.4 Product Benchmarking
14.5 Biocon
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2017-2022
14.5.3.2 R&D, 2017-2022
14.5.3.3 Regional Market Shares, 2022
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Cipla Inc.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2017-2022
14.6.3.2 R&D, 2017-2022
14.6.3.3 Regional Market Shares, 2022
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Divi's Laboratories Limited
14.7.1 Company Snapshot
14.7.2 Company Overviews
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2017-2022
14.7.3.2 R&D, 2017-2022
14.7.3.3 Regional Market Shares, 2022
14.7.4 Product Benchmarking
14.8 Dr. Reddy’s Laboratories Ltd.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2017-2022
14.8.3.2 R&D, 2017-2022
14.8.3.3 Regional Market Shares, 2022
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 EUROAPI
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2017-2022
14.9.3.2 R&D, 2017-2022
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 HIKAL Ltd.
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2017-2022
14.10.3.2 R&D, 2017-2022
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Merck & Co., Inc.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2017-2022
14.11.3.2 R&D, 2017-2022
14.11.3.3 Regional Market Shares, 2022
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 Teva Pharmaceutical Industries Ltd.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2017-2022
14.12.3.2 R&D, 2017-2022
14.12.3.3 Regional Market Shares, 2022
14.12.4 Product Benchmarking

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1 Active Pharmaceutical Ingredients Market Snapshot, 2023 & 2033 (US$ Billion, CAGR %)
Table 2 Active Pharmaceutical Ingredients Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Active Pharmaceutical Ingredients Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Active Pharmaceutical Ingredients Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Active Pharmaceutical Ingredients Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 7 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 8 Anti-diabetics Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 9 Pulmonology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 10 Immuno-suppressants Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 11 Neurology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 12 Cardiology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 13 Ophthalmology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 14 Orthopaedic Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 15 Others Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 16 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 17 Synthetic Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 18 Biotech Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 19 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 20 Merchant API Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 21 Captive API Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 22 Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 23 Branded Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 24 Generic Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 25 Active Pharmaceutical Ingredients Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 26 North America Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 27 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 28 North America Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 29 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 30 North America Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 31 U.S. Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 32 Canada Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 33 Europe Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 34 Europe Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 35 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 36 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 37 Europe Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 38 Germany Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 39 France Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 40 UK Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 41 Italy Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 42 Spain Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 43 Russia Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 44 Rest of Europe Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 45 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 46 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 47 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 48 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 49 Asia Pacific Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 50 Japan Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 51 China Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 52 India Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 53 Australia Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 54 South Korea Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 55 Rest of Asia Pacific Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 56 Latin America Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 57 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 58 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 59 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 60 Latin America Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 61 Brazil Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 62 Mexico Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 63 Rest of Latin America Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 64 MEA Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 65 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 66 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 67 Active Pharmaceutical Ingredients Market Manufacturer, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 68 MEA Active Pharmaceutical Ingredients Market Drug Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 69 GCC Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 70 South Africa Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 71 Rest of MEA Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR %)
Table 72 Strategic Outlook
Table 73 Aarti Drugs Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Aarti Drugs Ltd.: Product Benchmarking
Table 75 Aurobindo Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Aurobindo Pharma: Product Benchmarking
Table 77 Biocon: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 Biocon: Product Benchmarking
Table 79 Biocon: Strategic Outlook
Table 80 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Cipla Inc.: Product Benchmarking
Table 82 Cipla Inc.: Strategic Outlook
Table 83 Divi's Laboratories Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Divi's Laboratories Limited: Product Benchmarking
Table 85 Dr. Reddy’s Laboratories Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Dr. Reddy’s Laboratories Ltd.: Product Benchmarking
Table 87 Dr. Reddy’s Laboratories Ltd.: Strategic Outlook
Table 88 EUROAPI: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 EUROAPI: Product Benchmarking
Table 90 EUROAPI: Strategic Outlook
Table 91 HIKAL Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 HIKAL Ltd.: Product Benchmarking
Table 93 HIKAL Ltd.: Strategic Outlook
Table 94 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Merck & Co., Inc.: Product Benchmarking
Table 96 Merck & Co., Inc.: Strategic Outlook
Table 97 Teva Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Teva Pharmaceutical Industries Ltd.: Product Benchmarking

List of Figures
Figure 1 Active Pharmaceutical Ingredients Market Segmentation
Figure 2 Active Pharmaceutical Ingredients Market by Therapeutic Application: Market Attractiveness Index
Figure 3 Active Pharmaceutical Ingredients Market by Synthesis Type: Market Attractiveness Index
Figure 4 Active Pharmaceutical Ingredients Market by Manufacturer: Market Attractiveness Index
Figure 5 Active Pharmaceutical Ingredients Market by Drug Type: Market Attractiveness Index
Figure 6 Active Pharmaceutical Ingredients Market Attractiveness Index by Region
Figure 7 Active Pharmaceutical Ingredients Market: Market Dynamics
Figure 8 Active Pharmaceutical Ingredients Market by Region, 2023-2033 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 9 Active Pharmaceutical Ingredients Market by Region, 2023-2033 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 10 Active Pharmaceutical Ingredients Market by Region, 2023-2033 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 11 Active Pharmaceutical Ingredients Market by Region, 2023-2033 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 12 Active Pharmaceutical Ingredients Market: Porter’s Five Forces Analysis
Figure 13 Active Pharmaceutical Ingredients Market: PEST Analysis
Figure 14 Active Pharmaceutical Ingredients Market by Therapeutic Application: Market Attractiveness Index
Figure 15 Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 16 Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023, 2028, 2033 (%)
Figure 17 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 18 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Anti-diabetics Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 20 Anti-diabetics Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Pulmonology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 22 Pulmonology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Immuno-suppressants Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 24 Immuno-suppressants Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Neurology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 26 Neurology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Cardiology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 28 Cardiology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Ophthalmology Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 30 Ophthalmology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Orthopaedic Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 32 Orthopaedic Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 Others Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 34 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 35 Active Pharmaceutical Ingredients Market by Synthesis Type: Market Attractiveness Index
Figure 36 Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 37 Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023, 2028, 2033 (%)
Figure 38 Synthetic Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 39 Synthetic Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 Biotech Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 41 Biotech Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 42 Active Pharmaceutical Ingredients Market by Manufacturer: Market Attractiveness Index
Figure 43 Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 44 Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023, 2028, 2033 (%)
Figure 45 Merchant API Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 46 Merchant API Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Captive API Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 48 Captive API Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Active Pharmaceutical Ingredients Market by Drug Type: Market Attractiveness Index
Figure 50 Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 51 Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023, 2028, 2033 (%)
Figure 52 Branded Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 53 Branded Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 54 Generic Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 55 Generic Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Active Pharmaceutical Ingredients Market Forecast by Region 2023 and 2033 (Revenue, CAGR %)
Figure 57 Active Pharmaceutical Ingredients Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 58 Active Pharmaceutical Ingredients Market by Region, 2023-2033 (US$ Billion, AGR %)
Figure 59 North America Active Pharmaceutical Ingredients Market Attractiveness Index
Figure 60 North America Active Pharmaceutical Ingredients Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 61 North America Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 62 North America Active Pharmaceutical Ingredients Market Share Forecast by Country, 2023 & 2033 (%)
Figure 63 North America Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 64 North America Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023 & 2033 (%)
Figure 65 North America Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 66 North America Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023 & 2033 (%)
Figure 67 North America Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 68 North America Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023 & 2033 (%)
Figure 69 North America Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 70 North America Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 71 U.S. Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 72 Canada Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 73 Europe Active Pharmaceutical Ingredients Market Attractiveness Index
Figure 74 Europe Active Pharmaceutical Ingredients Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 75 Europe Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 76 Europe Active Pharmaceutical Ingredients Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 Europe Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 78 Europe Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023 & 2033 (%)
Figure 79 Europe Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 80 Europe Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023 & 2033 (%)
Figure 81 Europe Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 82 Europe Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023 & 2033 (%)
Figure 83 Europe Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 84 Europe Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 85 Germany Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 86 France Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 87 UK Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 88 Italy Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 89 Spain Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 90 Russia Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 91 Rest of Europe Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 92 Asia Pacific Active Pharmaceutical Ingredients Market Attractiveness Index
Figure 93 Asia Pacific Active Pharmaceutical Ingredients Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 94 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 95 Asia Pacific Active Pharmaceutical Ingredients Market Share Forecast by Country, 2023 & 2033 (%)
Figure 96 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 97 Asia Pacific Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023 & 2033 (%)
Figure 98 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 99 Asia Pacific Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023 & 2033 (%)
Figure 100 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 101 Asia Pacific Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023 & 2033 (%)
Figure 102 Asia Pacific Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 103 Asia Pacific Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 104 Japan Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 105 China Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 106 India Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 107 Australia Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 108 South Korea Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 109 Rest of Asia Pacific Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 110 Latin America Active Pharmaceutical Ingredients Market Attractiveness Index
Figure 111 Latin America Active Pharmaceutical Ingredients Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 112 Latin America Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 113 Latin America Active Pharmaceutical Ingredients Market Share Forecast by Country, 2023 & 2033 (%)
Figure 114 Latin America Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 115 Latin America Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023 & 2033 (%)
Figure 116 Latin America Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 117 Latin America Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023 & 2033 (%)
Figure 118 Latin America Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 119 Latin America Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023 & 2033 (%)
Figure 120 Latin America Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 121 Latin America Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 122 Brazil Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 123 Mexico Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 124 Rest of Latin America Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 125 MEA Active Pharmaceutical Ingredients Market Attractiveness Index
Figure 126 MEA Active Pharmaceutical Ingredients Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 127 MEA Active Pharmaceutical Ingredients Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
Figure 128 MEA Active Pharmaceutical Ingredients Market Share Forecast by Country, 2023 & 2033 (%)
Figure 129 MEA Active Pharmaceutical Ingredients Market Forecast by Therapeutic Application, 2023-2033 (US$ Billion, AGR %)
Figure 130 MEA Active Pharmaceutical Ingredients Market Share Forecast by Therapeutic Application, 2023 & 2033 (%)
Figure 131 MEA Active Pharmaceutical Ingredients Market Forecast by Synthesis Type, 2023-2033 (US$ Billion, AGR %)
Figure 132 MEA Active Pharmaceutical Ingredients Market Share Forecast by Synthesis Type, 2023 & 2033 (%)
Figure 133 MEA Active Pharmaceutical Ingredients Market Forecast by Manufacturer, 2023-2033 (US$ Billion, AGR %)
Figure 134 MEA Active Pharmaceutical Ingredients Market Share Forecast by Manufacturer, 2023 & 2033 (%)
Figure 135 MEA Active Pharmaceutical Ingredients Market Forecast by Drug Type, 2023-2033 (US$ Billion, AGR %)
Figure 136 MEA Active Pharmaceutical Ingredients Market Share Forecast by Drug Type, 2023 & 2033 (%)
Figure 137 GCC Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 138 South Africa Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 139 Rest of MEA Active Pharmaceutical Ingredients Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 140 Aarti Drugs Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 141 Aarti Drugs Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 142 Aarti Drugs Ltd.: Regional Market Shares, 2022
Figure 143 Aurobindo Pharma: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 144 Aurobindo Pharma: R&D, 2017-2022 (US$ Million, AGR%)
Figure 145 Aurobindo Pharma: Regional Market Shares, 2022
Figure 146 Biocon: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 147 Biocon: R&D, 2017-2022 (US$ Million, AGR%)
Figure 148 Biocon: Regional Market Shares, 2022
Figure 149 Cipla Ltd: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 150 Cipla Ltd: R&D, 2017-2022 (US$ Million, AGR %)
Figure 151 Cipla Inc.: Regional Market Shares, 2022
Figure 152 Divi's Laboratories Limited: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 153 Divi's Laboratories Limited: R&D, 2017-2022 (US$ Million, AGR%)
Figure 154 Divi's Laboratories Limited: Regional Market Shares, 2022
Figure 155 Dr. Reddy’s Laboratories Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 156 Dr. Reddy’s Laboratories Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 157 Dr. Reddy’s Laboratories Ltd.: Regional Market Shares, 2022
Figure 158 EUROAPI: Net Revenue, 2019-2022 (US$ Million, AGR%)
Figure 159 EUROAPI: R&D, 2021-2022 (US$ Million, AGR%)
Figure 160 HIKAL Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 161 HIKAL Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 162 Merck & Co., Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 163 Merck & Co., Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 164 Merck & Co., Inc.: Regional Market Shares, 2022
Figure 165 Teva Pharmaceutical Industries Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 166 Teva Pharmaceutical Industries Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 167 Teva Pharmaceutical Industries Ltd.: Regional Market Shares, 2022

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（薬学的薬物）の最新刊レポート

皮膚科治療薬市場レポート：2024-2034

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（active pharmaceutical）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

原薬市場レポート 2023-2033

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（薬学的薬物）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（active pharmaceutical）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?